<p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）內部人士 Mario Schlosser 於 11 月 11 日（星期二）出售了 286,182 股 Oscar Health 股票。股票的平均售價為 15.27 美元，總價值為 4,369,999.14 美元。出售完成後，該內部人士在公司持有 501,148 股，價值為 7,652,529.96 美元。這代表其持股比例減少了 36.35%。該交易已在提交給證券交易委員會的文件中披露，相關文件可在 SEC 網站上查閲。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>Mario Schlosser 最近還進行了以下交易：</p>
<ul>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。股票的平均售價為 18.43 美元，總價值為 7,279,850.00 美元。</li>
</ul>
<h2>Oscar Health 股票下跌 4.2%</h2>
<p>OSCR 的股票在星期四開盤價為 14.09 美元。該公司的 50 日移動平均價格為 18.51 美元，200 日移動平均價格為 16.91 美元。Oscar Health, Inc.的 12 個月低點為 11.20 美元，12 個月高點為 23.80 美元。該公司的流動比率為 0.92，速動比率為 0.92，債務與股本比率為 0.67。該公司的市值為 37.3 億美元，市盈率為-12.58，貝塔係數為 1.88。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 11 月 6 日（星期四）公佈了其財報。公司報告本季度每股收益為（0.53 美元），超出市場共識預期的（0.55 美元）0.02 美元。該季度的收入為 29.3 億美元，而分析師預期為 30.9 億美元。Oscar Health 的淨利潤率為-2.16%，股本回報率為-21.50%。與去年同期相比，Oscar Health 的收入增長了 23.2%。去年同期，該公司每股收益為（0.22 美元）。Oscar Health 已將 2025 財年的指引設定為每股收益。平均而言，賣方分析師預測 Oscar Health, Inc.今年的每股收益為 0.69 美元。</p>
<h2>機構投資者對 Oscar Health 的看法</h2>
<p>一些對沖基金最近買入和賣出了 OSCR 的股票。Vanguard Group Inc.在第三季度將其在 Oscar Health 的持股增加了 2.1%。Vanguard Group Inc.目前持有 20,160,399 股該公司的股票，價值為 381,636,000 美元，在上個季度又購買了 423,184 股。T. Rowe Price Investment Management Inc.在第一季度將其在 Oscar Health 的股份增加了 4.1%。T. Rowe Price Investment Management Inc.目前持有 11,826,245 股該公司的股票，價值為 155,043,000 美元，在上個季度又收購了 467,301 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的股份增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股該公司的股票，價值為 85,258,000 美元，在上個季度又收購了 1,588,395 股。American Century Companies Inc.在第三季度將其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.目前持有 5,298,340 股該公司的股票，價值為 100,298,000 美元，在上個季度又收購了 2,495,691 股。最後，BIT Capital GmbH 在第一季度將其在 Oscar Health 的持股增加了 1.1%。BIT Capital GmbH 目前持有 4,521,445 股該公司的股票，價值為 59,276,000 美元，在上個季度又購買了 47,592 股。機構投資者和對沖基金持有該公司 75.70% 的股票。</p>
<h2>華爾街分析師預測增長</h2>
<p>一些研究分析師對該公司進行了評論。Wells Fargo &amp; Company 在 11 月 13 日（星期四）的研究報告中將 Oscar Health 的目標價從 14.00 美元下調至 11.00 美元，並對該股票給予了 “減持” 評級。Zacks Research 在 10 月 13 日（星期一）的報告中將 Oscar Health 的評級從 “強烈賣出” 上調至 “持有”。Piper Sandler 在 8 月 14 日（星期四）的研究報告中將 Oscar Health 的目標價從 14.00 美元下調至 13.00 美元，並對該公司給予了 “中性” 評級。UBS Group 在 11 月 7 日（星期五）的研究報告中將 Oscar Health 的目標價從 11.00 美元上調至 12.00 美元，並對該股票給予了 “賣出” 評級。最後，Weiss Ratings 在 10 月 8 日（星期三）的研究報告中重新發布了對 Oscar Health 的 “賣出（d）” 評級。六位投資分析師對該股票給予了持有評級，五位分析師給予了賣出評級。根據 MarketBeat 的數據，Oscar Health 目前的平均評級為 “減持”，平均目標價為 13.14 美元。</p>
<p><strong>查看我們對 Oscar Health 的最新分析</strong></p>
<h2>Oscar Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Oscar Health, Inc.在美國運營健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉變。它還提供再保險產品。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Oscar Health</li>
<li>在 52 周高點盈利交易股票</li>
<li>onsemi 對其自身股票下注 60 億美元</li>
<li>如何使用 MarketBeat 股息計算器</li>
<li>HIMS 經歷了過山車般的旅程。投資者應該上車嗎？</li>
<li>經紀評級在股票選擇中的重要性</li>
<li>用這三隻反彈冠軍強勢結束年末</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

<p>Oscar Health 內部人士 Mario Schlosser 以每股 15.27 美元的價格出售了 286,182 股，總計 437 萬美元，減少了 36.35% 的持股比例。該交易在 SEC 文件中披露。Oscar Health 的股票開盤價為 14.09 美元，市值為 37.3 億美元。公司報告的季度每股收益為（0.53 美元），超出預期。機構投資者持有 75.70% 的股票。分析師的評級不一，目標價格範圍在 11 美元到 13 美元之間</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at $7,652,529.96. This represents a 36.35% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at the SEC website.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 獲取免費報告）內部人士 Mario Schlosser 於 11 月 11 日（星期二）出售了 286,182 股 Oscar Health 股票。股票的平均售價為 15.27 美元，總價值為 4,369,999.14 美元。出售完成後，該內部人士在公司持有 501,148 股，價值為 7,652,529.96 美元。這代表其持股比例減少了 36.35%。該交易已在提交給證券交易委員會的文件中披露，相關文件可在 SEC 網站上查閲。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>Mario Schlosser also recently made the following trade(s):</p>
<div class="lb-trans"><p>Mario Schlosser 最近還進行了以下交易：</p>
</div><ul>
<li>On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。股票的平均售價為 18.43 美元，總價值為 7,279,850.00 美元。</li>
</ul>
</div><h2>Oscar Health Stock Down 4.2%</h2>
<div class="lb-trans"><h2>Oscar Health 股票下跌 4.2%</h2>
</div><p>Shares of OSCR opened at $14.09 on Thursday. The company's 50-day moving average price is $18.51 and its 200 day moving average price is $16.91. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market cap of $3.73 billion, a P/E ratio of -12.58 and a beta of 1.88.</p>
<div class="lb-trans"><p>OSCR 的股票在星期四開盤價為 14.09 美元。該公司的 50 日移動平均價格為 18.51 美元，200 日移動平均價格為 16.91 美元。Oscar Health, Inc.的 12 個月低點為 11.20 美元，12 個月高點為 23.80 美元。該公司的流動比率為 0.92，速動比率為 0.92，債務與股本比率為 0.67。該公司的市值為 37.3 億美元，市盈率為-12.58，貝塔係數為 1.88。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. Oscar Health's revenue was up 23.2% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 11 月 6 日（星期四）公佈了其財報。公司報告本季度每股收益為（0.53 美元），超出市場共識預期的（0.55 美元）0.02 美元。該季度的收入為 29.3 億美元，而分析師預期為 30.9 億美元。Oscar Health 的淨利潤率為-2.16%，股本回報率為-21.50%。與去年同期相比，Oscar Health 的收入增長了 23.2%。去年同期，該公司每股收益為（0.22 美元）。Oscar Health 已將 2025 財年的指引設定為每股收益。平均而言，賣方分析師預測 Oscar Health, Inc.今年的每股收益為 0.69 美元。</p>
</div><h2>Institutional Investors Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>機構投資者對 Oscar Health 的看法</h2>
</div><p>A number of hedge funds have recently bought and sold shares of OSCR. Vanguard Group Inc. grew its position in shares of Oscar Health by 2.1% during the third quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock worth $381,636,000 after buying an additional 423,184 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC lifted its stake in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. grew its holdings in Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after acquiring an additional 2,495,691 shares in the last quarter. Finally, BIT Capital GmbH increased its position in shares of Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.</p>
<div class="lb-trans"><p>一些對沖基金最近買入和賣出了 OSCR 的股票。Vanguard Group Inc.在第三季度將其在 Oscar Health 的持股增加了 2.1%。Vanguard Group Inc.目前持有 20,160,399 股該公司的股票，價值為 381,636,000 美元，在上個季度又購買了 423,184 股。T. Rowe Price Investment Management Inc.在第一季度將其在 Oscar Health 的股份增加了 4.1%。T. Rowe Price Investment Management Inc.目前持有 11,826,245 股該公司的股票，價值為 155,043,000 美元，在上個季度又收購了 467,301 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的股份增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股該公司的股票，價值為 85,258,000 美元，在上個季度又收購了 1,588,395 股。American Century Companies Inc.在第三季度將其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.目前持有 5,298,340 股該公司的股票，價值為 100,298,000 美元，在上個季度又收購了 2,495,691 股。最後，BIT Capital GmbH 在第一季度將其在 Oscar Health 的持股增加了 1.1%。BIT Capital GmbH 目前持有 4,521,445 股該公司的股票，價值為 59,276,000 美元，在上個季度又購買了 47,592 股。機構投資者和對沖基金持有該公司 75.70% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>A number of research analysts have commented on the company. Wells Fargo &amp; Company decreased their price target on Oscar Health from $14.00 to $11.00 and set an &#34;underweight&#34; rating on the stock in a research note on Thursday, November 13th. Zacks Research upgraded Oscar Health from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Monday, October 13th. Piper Sandler dropped their target price on Oscar Health from $14.00 to $13.00 and set a &#34;neutral&#34; rating for the company in a research report on Thursday, August 14th. UBS Group increased their price target on shares of Oscar Health from $11.00 to $12.00 and gave the stock a &#34;sell&#34; rating in a research report on Friday, November 7th. Finally, Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Oscar Health in a research note on Wednesday, October 8th. Six investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Oscar Health presently has an average rating of &#34;Reduce&#34; and an average target price of $13.14.</p>
<div class="lb-trans"><p>一些研究分析師對該公司進行了評論。Wells Fargo &amp; Company 在 11 月 13 日（星期四）的研究報告中將 Oscar Health 的目標價從 14.00 美元下調至 11.00 美元，並對該股票給予了 “減持” 評級。Zacks Research 在 10 月 13 日（星期一）的報告中將 Oscar Health 的評級從 “強烈賣出” 上調至 “持有”。Piper Sandler 在 8 月 14 日（星期四）的研究報告中將 Oscar Health 的目標價從 14.00 美元下調至 13.00 美元，並對該公司給予了 “中性” 評級。UBS Group 在 11 月 7 日（星期五）的研究報告中將 Oscar Health 的目標價從 11.00 美元上調至 12.00 美元，並對該股票給予了 “賣出” 評級。最後，Weiss Ratings 在 10 月 8 日（星期三）的研究報告中重新發布了對 Oscar Health 的 “賣出（d）” 評級。六位投資分析師對該股票給予了持有評級，五位分析師給予了賣出評級。根據 MarketBeat 的數據，Oscar Health 目前的平均評級為 “減持”，平均目標價為 13.14 美元。</p>
</div><p><strong>View Our Latest Analysis on Oscar Health</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Oscar Health 的最新分析</strong></p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美國運營健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉變。它還提供再保險產品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Profitably Trade Stocks at 52-Week Highs</li>
<li>onsemi Places a $6 Billion Bet on Its Own Stock</li>
<li>How to Use the MarketBeat Dividend Calculator</li>
<li>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</li>
<li>The Significance of Brokerage Rankings in Stock Selection</li>
<li>End the Year Strong With These 3 Comeback Champions</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Oscar Health</li>
<li>在 52 周高點盈利交易股票</li>
<li>onsemi 對其自身股票下注 60 億美元</li>
<li>如何使用 MarketBeat 股息計算器</li>
<li>HIMS 經歷了過山車般的旅程。投資者應該上車嗎？</li>
<li>經紀評級在股票選擇中的重要性</li>
<li>用這三隻反彈冠軍強勢結束年末</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

內部人士拋售：Oscar Health（NYSE:OSCR）的內部人士出售了 286,182 股股票